Efficacy and safety of everolimus in Chinese metastatic HR positive, HER2 negative breast cancer patients: a real-world retrospective study

Benzer Materyaller

• Comparative Treatment Patterns and Outcomes of Fulvestrant versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-World Experience
  Yazar:: Li, Yi, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Optimal duration of prior endocrine therapy predicts the efficacy of Fulvestrant in a real‐world study for patients with hormone receptor‐positive and HER2‐negative advanced breast cancer
  Yazar:: Zhao, Yannan, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Real-world outcomes of trastuzumab deruxtecan in HR-negative HER2-low metastatic breast cancer
  Yazar:: Mengqian Ni, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-11-01)
• Real-World Data of Pyrotinib-Based Therapy in Metastatic HER2-Positive Breast Cancer: Promising Efficacy in Lapatinib-Treated Patients and in Brain Metastasis
  Yazar:: Lin, Ying, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Everolimus‐Related Pneumonitis in Patients with Metastatic Breast Cancer: Incidence, Radiographic Patterns, and Relevance to Clinical Outcome
  Yazar:: Gong, Chengcheng, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)